Compare SIMO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIMO | ELAN |
|---|---|---|
| Founded | 1995 | 1954 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.8B |
| IPO Year | 2005 | 2018 |
| Metric | SIMO | ELAN |
|---|---|---|
| Price | $300.71 | $25.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $118.13 | $27.89 |
| AVG Volume (30 Days) | 877.8K | ★ 4.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $42.27 | $8.21 |
| Revenue Next Year | $12.78 | $5.31 |
| P/E Ratio | ★ $36.09 | $226.59 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $70.12 | $13.39 |
| 52 Week High | $355.00 | $27.72 |
| Indicator | SIMO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 58.10 |
| Support Level | $91.95 | $22.33 |
| Resistance Level | $314.34 | $25.58 |
| Average True Range (ATR) | 24.43 | 0.84 |
| MACD | -2.00 | 0.04 |
| Stochastic Oscillator | 42.85 | 90.63 |
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid-state storage devices. Its only operating segment is to develop NAND flash controllers and SSD solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company's products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.